Diagnóstico y tratamiento de la neutropenia febril en el paciente oncohematológico

Barroso Sánchez, Gustavo; Quintero Sierra, Yamilé; Rivas Cruz, Yoel Carlos.
Rev. cuba. hematol. inmunol. hemoter ; 36(4): e1285, oct.-dic. 2020. tab
Artículo en Español | LILACS, CUMED | ID: biblio-1289413

Documentos relacionados

  1. The application of nanopore targeted sequencing in the diagnosis and antimicrobial treatment guidance of bloodstream infection of febrile neutropenia patients with hematologic disease.
  2. Plasma Microbial Cell-free DNA Next-generation Sequencing in the Diagnosis and Management of Febrile Neutropenia.
  3. Internal evaluation of risk stratification tool using serial procalcitonin and clinical risk factors in pediatric febrile neutropenia: The non-interventional, single institution experience prior to clinical implementation.
  4. A comprehensive assessment of the prolonged febrile neutropenia evaluation in pediatric oncology patients.
  5. Cytokine and chemokine profiles in episodes of persistent high-risk febrile neutropenia in children with cancer.
  6. Optimized blood culture strategy to document febrile neutropenia.
  7. Use of wide-spectrum antimicrobials with blood culture tests during chemotherapy as an accurate marker of febrile neutropenia in the DPC database: A validation study.
  8. Managing febrile neutropenia in the UK in 2020.
  9. High-frequency temperature monitoring at home using a wearable device: A case series of early fever detection and antibiotic administration for febrile neutropenia with bacteremia.
  10. CISNE versus MASCC: Identifying low risk febrile neutropenic patients.